Copyright
©The Author(s) 2021.
World J Clin Cases. Nov 16, 2021; 9(32): 9770-9782
Published online Nov 16, 2021. doi: 10.12998/wjcc.v9.i32.9770
Published online Nov 16, 2021. doi: 10.12998/wjcc.v9.i32.9770
Variables (cut-off value) | Sensitivity | Specificity | PPV |
Intrahepatic bile duct cancer | |||
CA19-9 (255 IU/mL) | 0.833 | 0.667 | 0.313 |
CEA (7 ng/mL) | 0.500 | 0.849 | 0.333 |
NLR (3) | 0.500 | 0.636 | 0.200 |
Extrahepatic bile duct cancer | |||
CA19-9 (255 IU/mL) | 0.273 | 0.787 | 0.125 |
CEA (7 ng/mL) | 0.273 | 0.939 | 0.333 |
NLR (3) | 0.455 | 0.727 | 0.152 |
Gallbladder cancer | |||
CA19-9 (255 IU/mL) | 0.444 | 0.878 | 0.444 |
CEA (7 ng/mL) | 0.444 | 0.878 | 0.444 |
NLR (3) | 0.889 | 0.659 | 0.364 |
- Citation: Hashimoto Y, Ajiki T, Yanagimoto H, Tsugawa D, Shinozaki K, Toyama H, Kido M, Fukumoto T. Risk factors for occult metastasis detected by inflammation-based prognostic scores and tumor markers in biliary tract cancer. World J Clin Cases 2021; 9(32): 9770-9782
- URL: https://www.wjgnet.com/2307-8960/full/v9/i32/9770.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i32.9770